全文获取类型
收费全文 | 5314篇 |
免费 | 537篇 |
国内免费 | 220篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 53篇 |
妇产科学 | 35篇 |
基础医学 | 1097篇 |
口腔科学 | 234篇 |
临床医学 | 345篇 |
内科学 | 965篇 |
皮肤病学 | 56篇 |
神经病学 | 356篇 |
特种医学 | 79篇 |
外国民族医学 | 1篇 |
外科学 | 284篇 |
综合类 | 554篇 |
现状与发展 | 2篇 |
预防医学 | 229篇 |
眼科学 | 83篇 |
药学 | 985篇 |
1篇 | |
中国医学 | 155篇 |
肿瘤学 | 537篇 |
出版年
2024年 | 8篇 |
2023年 | 129篇 |
2022年 | 117篇 |
2021年 | 281篇 |
2020年 | 242篇 |
2019年 | 206篇 |
2018年 | 193篇 |
2017年 | 204篇 |
2016年 | 235篇 |
2015年 | 299篇 |
2014年 | 382篇 |
2013年 | 577篇 |
2012年 | 335篇 |
2011年 | 418篇 |
2010年 | 316篇 |
2009年 | 292篇 |
2008年 | 274篇 |
2007年 | 232篇 |
2006年 | 198篇 |
2005年 | 180篇 |
2004年 | 139篇 |
2003年 | 99篇 |
2002年 | 74篇 |
2001年 | 71篇 |
2000年 | 56篇 |
1999年 | 50篇 |
1998年 | 44篇 |
1997年 | 40篇 |
1996年 | 31篇 |
1995年 | 28篇 |
1994年 | 32篇 |
1993年 | 28篇 |
1992年 | 31篇 |
1991年 | 23篇 |
1990年 | 22篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 16篇 |
1985年 | 23篇 |
1984年 | 12篇 |
1983年 | 15篇 |
1982年 | 11篇 |
1981年 | 18篇 |
1980年 | 15篇 |
1979年 | 8篇 |
1978年 | 10篇 |
1977年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有6071条查询结果,搜索用时 46 毫秒
1.
Mixed lineage leukemia 1(MLL1)是组蛋白甲基转移酶SET家族的成员之一。MLL1与WDR5、RbBP5、Ash2L和DPY-30组成MLL1甲基转移酶复合物调控组蛋白H3的第4位赖氨酸的甲基化水平,对造血系统的发育和血细胞的更新至关重要。部分白血病患者体内存在因MLL1基因易位而产生的致癌蛋白——MLL1融合蛋白,MLL1融合蛋白在发挥其致癌作用时需要功能完整的MLL1酶复合物,故靶向MLL1-WDR5的蛋白-蛋白相互作用成为治疗MLL1融合型白血病的潜在策略。本文对MLL1-WDR5蛋白-蛋白相互作用的生物学机制、结构信息以及抑制剂进行了系统的总结,并结合已报道数据对该领域进行了展望,以期为后续研究提供参考。 相似文献
2.
3.
4.
5.
6.
Yasuaki Ogura Kensuke Fukuchi Hiroki Morimoto Tsurumi Yuki Masaki Otsuka Takatoshi Shimauchi Tetsuya Honda Yoshiki Tokura 《The Journal of dermatology》2022,49(1):124-132
Mamushi bites cause swelling and pain that extend from the bitten site. The coagulopathic, anti-coagulopathic, and vasculopathic actions of mamushi venom result in various laboratory abnormalities, occasionally with muscular, renal, and other organ damage. We investigated the serum biomarkers that were associated with the pathogenesis of mamushi bites, focusing on markers related to tissue-damage and neutrophil activation. Twenty patients (one case of grade 2, 13 cases of grade 3, and six cases of grade 4 of severity) seen by us in one summer season were enrolled. Peripheral blood samples were taken from the patients on day 0, day 2, and day 7 after mamushi bites. In addition to routine blood examination, serum samples were subjected to enzyme-linked immunosorbent assay for citrullinated histone H3 (CitH3), interleukin (IL)-8, IL-17A, IL-22, vascular endothelial growth factor (VEGF), high mobility group box protein 1 (HMGB1), tumor necrosis factor (TNF)-α, and IL-33. Creatinine kinase (CK) values significantly correlated with prothrombin time (PT) levels, suggesting that muscular damage is associated with exaggerated coagulation and fibrinolysis. In the vast majority of patients, HMGB1, TNF-α, and IL-33 were under detection levels. Neutrophil counts did not correlate with PT or CK, indicating that the coagulation disorder and muscular damage were virtually independent of the neutrophil activation. The neutrophil number significantly correlated with CitH3, a representative marker of neutrophil extracellular traps. Moreover, there were significant correlations between neutrophil number, CitH3, IL-8, IL-22, and VEGF. Our study suggests that there are two major cascades in mamushi bites. One is an already characterized venom effect on coagulation, vessels, and muscles. In the other novel cascade, we propose that neutrophil activation with IL-8 leads to the production of IL-22 and VEGF. This sequential event may contribute to both vascular damage and repair. 相似文献
7.
Macrophages are the most abundant immune cells in the lung, which play an important role in COPD. The anti-inflammatory and anti-oxidation of ergosterol are well documented. However, the effect of ergosterol on macrophage polarization has not been studied. The objective of this work was to investigate the effect of ergosterol on macrophage polarization in CSE-induced RAW264.7 cells and Sprague-Dawley (SD) rats COPD model. Our results demonstrate that CSE-induced macrophages tend to the M1 polarization via increasing ROS, IL-6 and TNF-α, as well as increasing MMP-9 to destroy the lung construction in both RAW264.7 cells and SD rats. However, treatment of RAW264.7 cells and SD rats with ergosterol inhibited CSE-induced inflammatory by decreasing ROS, IL-6 and TNF-α, and increasing IL-10 and TGF-β, shuffling the dynamic polarization of macrophages from M1 to M2 both in vitro and in vivo. Ergosterol also decreased the expression of M1 marker CD40, while increased that of M2 marker CD163. Moreover, ergosterol improved the lung characters in rats by decreasing MMP-9. Furthermore, ergosterol elevated HDAC3 activation and suppressed P300/CBP and PCAF activation as well as acetyl NF-κB/p65 and IKKβ, demonstrating that HDAC3 deacetylation was involved in the effect of ergosterol on macrophage polarization. These results also provide a proof in immunoregulation of ergosterol for therapeutic effects of cultured C. sinensis on COPD patients. 相似文献
8.
目的:研究组蛋白去乙酰化酶1(histone deacetylase 1,HDAC1)和细胞周期蛋白依赖性激酶1(cyclin-dependent kinase 1,CDK1)在结肠癌组织中的表达水平及其与患者临床病理特征及预后的关系。方法:收集2012年2月至2013年6月在本院普外科进行手术切除的51例结肠癌患者的肿瘤组织和癌旁非肿瘤组织,采用qRT-PCR法检测组织中HDAC1和CDK1 mRNA相对表达量,采用免疫组织化学染色法检测HDAC1和CDK1蛋白阳性表达率,分析肿瘤组织中HDAC1和CDK1表达的相关性及其与患者肿瘤直径、淋巴结转移等临床病理特征的关系,采用Kaplan-Meier生存函数分析HDAC1和CDK1不同表达情况与患者5年总生存率的关系。结果:肿瘤组织中HDAC1和CDK1 mRNA表达水平和蛋白阳性表达率均高于癌旁非肿瘤组织(P<0.05);肿瘤组织中HDAC1表达水平与CDK1表达水平呈显著正相关(P=0.012);肿瘤组织中HDAC1表达与患者肿瘤直径和组织分化程度有关(P<0.05),CDK1与肿瘤直径、TNM分期、分化程度、淋巴结转移有关(P<0.05);HDAC1、CDK1阳性表达患者5年总生存率均低于其相应阴性表达患者(P<0.05),HDAC1和CDK1共阳性表达患者5年总生存率低于HDAC1和(或)CDK1阴性患者(P<0.05)。结论:HDAC1和CDK1在结肠癌组织中高表达,与患者不良预后有关且两者呈正相关,推测两者在促进结肠癌进展中可能存在协同作用。 相似文献
9.
目的:探讨脂肪和肥胖相关基因(FTO)对异位子宫内膜间质细胞(eESCs)纤维化的影响及其机制。方法:采用实时定量聚合酶链反应(qRT-PCR)检测子宫内膜异位症(EMs)患者病变组织中m6A相关基因的表达;通过慢病毒载体过表达FTO,在eESCs中检测纤维化相关基因的表达;通过m6A2 Target数据库和MeRIP-qPCR预测和验证eESCs中FTO与Toll样受体2(TLR2)的关系;Western blot法检测p38的蛋白表达变化。结果:FTO在EMs中表达下调(P <0.05);FTO过表达促进eESCs纤维化并抑制其增殖(P <0.05);在eESCs中,FTO通过TLR2 的m6A修饰途径上调其蛋白水平(P <0.05);FTO在eESCs中经TLR2/p38 信号通路促进细胞纤维化(P <0.05)。结论:FTO在EMs中低表达,上调FTO可能通过TLR2/p38信号通路促进eESCs纤维化。 相似文献
10.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献